|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:administeredBy
|
injection
|
|
gptkbp:affiliatedWith
|
aminoglycoside antibiotics
|
|
gptkbp:ATCCode
|
gptkb:J01GA01
|
|
gptkbp:CASNumber
|
gptkb:57-92-1
|
|
gptkbp:chemicalFormula
|
C21H39N7O12
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
pregnancy
|
|
gptkbp:discoveredBy
|
gptkb:Selman_Waksman
gptkb:Albert_Schatz
|
|
gptkbp:discoveredIn
|
1943
|
|
gptkbp:firstAntibioticEffectiveAgainst
|
tuberculosis
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits protein synthesis
|
|
gptkbp:meltingPoint
|
131°C
|
|
gptkbp:molecularWeight
|
581.57 g/mol
|
|
gptkbp:origin
|
soil bacterium
|
|
gptkbp:producedBy
|
gptkb:Streptomyces_griseus
|
|
gptkbp:PubChem_CID
|
19649
|
|
gptkbp:resistantTo
|
can develop in Mycobacterium tuberculosis
|
|
gptkbp:routeOfAdministration
|
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
nephrotoxicity
ototoxicity
|
|
gptkbp:target
|
bacterial ribosome
|
|
gptkbp:UNII
|
6DG9Y75771
|
|
gptkbp:usedFor
|
treatment of tuberculosis
treatment of plague
treatment of tularemia
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
included
|
|
gptkbp:bfsParent
|
gptkb:1397-89-3
gptkb:Process_for_the_Preparation_of_Streptomycin
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Streptomycin
|